|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 38/20 | |||
| A61K 47/18 | |||
| A61K 47/20 | |||
| A61P 27/04 | |||
| A61P 27/14 | |||
| A61P 27/02 |
| (11) | Number of the document | 3288536 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16722558.0 |
| Date of filing the European patent application | 2016-04-27 | |
| (97) | Date of publication of the European application | 2018-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/059398 |
| Date | 2016-04-27 |
| (87) | Number | WO 2016/174082 |
| Date | 2016-11-03 |
| (30) | Number | Date | Country code |
| 15165421 | 2015-04-28 | EP |
| (72) |
FLORIN-ROBERTSSON, Ebba, SE
FRANSSON, Jonas, SE
MOORE, Barry D., GB
|
| (73) |
Swedish Orphan Biovitrum AB (publ),
112 76 Stockholm,
SE
|
| (54) | COMPOSITIONS COMPRISING ANAKINRA |
| COMPOSITIONS COMPRISING ANAKINRA |